Legal Representation
Attorney
Joshua G. Gigger
Application History
3 events| Date | Code | Type | Description |
|---|---|---|---|
| Apr 9, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Apr 9, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 9, 2025 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
pharmaceutical products for the treatment of central nervous system diseases and disorders; pharmaceutical products for the treatment of vertigo, dizziness, and lightheadedness; pharmaceutical products for the treatment of symptomatic neurogenic orthostatic hypotension; pharmaceutical products for the treatment of symptoms caused by primary autonomic failure, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy; pharmaceutical products for the treatment of symptoms caused by Parkinson’s disease, multiple system atrophy, and pure autonomic failure
Classification
International Classes
005